These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 2599121
21. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities. Lejeune FJ, Pujol N, Liénard D, Mosimann F, Raffoul W, Genton A, Guillou L, Landry M, Chassot PG, Chiolero R, Bischof-Delaloye A, Leyvraz S, Mirimanoff RO, Bejkos D, Leyvraz PF. Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614 [Abstract] [Full Text] [Related]
26. TNF dose reduction in isolated limb perfusion. Grünhagen DJ, de Wilt JH, van Geel AN, Graveland WJ, Verhoef C, Eggermont AM. Eur J Surg Oncol; 2005 Nov; 31(9):1011-9. PubMed ID: 16099618 [Abstract] [Full Text] [Related]
27. [Hyperthermic-antiblastic isolation perfusion for advanced melanoma of the limbs. The technic, immediate results and a review of the literature]. Decian F, Balletto N, Camerini G, Depaoli M, D'Aniello R, Ameri A, Brisighella A, Bonalumi U, Bachi V, Civalleri D. Minerva Chir; 1990 Oct 15; 45(19):1227-37. PubMed ID: 2074944 [Abstract] [Full Text] [Related]
28. Long-term functional morbidity after mild hyperthermic isolated limb perfusion with melphalan. Vrouenraets BC, in't Veld GJ, Nieweg OE, van Slooten GW, van Dongen JA, Kroon BB. Eur J Surg Oncol; 1999 Oct 15; 25(5):503-8. PubMed ID: 10529261 [Abstract] [Full Text] [Related]
34. Long-term neuropathy after regional isolated perfusion with melphalan for melanoma of the limbs. Vrouenraets BC, Eggermont AM, Klaase JM, Van Geel BN, Van Dongen JA, Kroon BB. Eur J Surg Oncol; 1994 Dec 05; 20(6):681-5. PubMed ID: 7995421 [Abstract] [Full Text] [Related]
35. Treatment of in-transit metastases from cutaneous melanoma by isolation perfusion with tumour necrosis factor-alpha (TNF-alpha), melphalan and interferon-gamma (IFN-gamma). Dose-finding experience at the National Cancer Institute of Milan. Vaglini M, Santinami M, Manzi R, Inglese MG, Santoro N, Persiani L, Belli F. Melanoma Res; 1994 Mar 05; 4 Suppl 1():35-8. PubMed ID: 8038594 [Abstract] [Full Text] [Related]
37. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M, Study Group for Therapies of Rectal Malignancies (STORM). Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1129-39. PubMed ID: 16414206 [Abstract] [Full Text] [Related]
38. Multiple perfusions for melanoma. Krementz ET, Muchmore JH, Carter RD, Sutherland CM. Melanoma Res; 1994 Mar 15; 4 Suppl 1():39-44. PubMed ID: 8038595 [Abstract] [Full Text] [Related]
39. Efficacy of repeat isolated limb infusion with melphalan and actinomycin D for recurrent melanoma. Kroon HM, Lin DY, Kam PC, Thompson JF. Cancer; 2009 May 01; 115(9):1932-40. PubMed ID: 19288571 [Abstract] [Full Text] [Related]
40. Malignant melanoma in Turkey: a single institution's experience on 475 cases. Tas F, Kurul S, Camlica H, Topuz E. Jpn J Clin Oncol; 2006 Dec 01; 36(12):794-9. PubMed ID: 17060409 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]